Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Therapy Option For Advanced HER2 Breast Cancer Approved In Canada
Women living with HER2 positive breast cancer now have a new treatment option for the first time in almost ten years. Health Canada has approved TykerbTM (lapatinib ditosylate) tablets for use in combination with an oral chemotherapy, capecitabine (Xeloda®), for the treatment of patients with advanced or metastatic breast cancer whose tumours overexpress HER2 (ErbB2) and who have progressed following prior therapies including taxanes, anthracyclines and trastuzumab (Herceptin®). HER2 positive breast cancer is an aggressive form of the disease that affects approximately 20 per cent of breast cancer patients.[1]
generic viagra online
NewYork-Presbyterian/Columbia Implants 100th Heart Valve Replacement Without Open-Heart Surgery
Over the last four years, heart specialists at NewYork-Presbyterian Hospital/Columbia University Medical Center have implanted an innovative aortic heart valve replacement using a catheter-based approach that does not require open-heart surgery in a total of 100 patients -- the most of any U.S. medical center to date.
News of the day
54th Annual Meeting Of The Health Physics Society, July 12-16, 2009
How does Hollywood impact radiation perception? Can we treat cancer with microscopic particles acting like a Trojan horse? How does the radiation exposure our astronauts receive during space travel compare to their routine diagnostic radiology exams?
Mental Health

IFPMA Announces Johnson & Johnson As New Member Company

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to announce that Johnson & Johnson has become its newest member company. IFPMA Acting Director General Michael D. Boyd said: "Johnson & Johnson is an important company in our industry and one which is particularly active in working to help improve health in developing countries. The IFPMA is very pleased that Johnson & Johnson has joined; this is good for the IFPMA, and we expect it will benefit Johnson & Johnson, as well." Johnson & Johnson is the world"s most comprehensive healthcare company, with more than 250 companies in 57 countries employing 119,000 people worldwide engaged in the research and development, manufacture and sales of a broad range of health care products, including pharmaceuticals, medical devices and diagnostics. Its worldwide headquarters is in New Brunswick, New Jersey, USA. The company is committed to bringing innovative ideas, products and services to market that advance the health and well-being of people throughout the world. For general information on Johnson & Johnson, please go to http://www.jnj.com. For information on the company"s activities to help improve health in underserved communities, please go to http://www.jnj.com/connect/caring/medicine-access/. IFPMA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009